A KOL describes the treatment pathways for lower- and higher-risk MDS patients and discusses current treatment and reimbursement challenges. Key clinical trials and drugs in active development are also discussed as well as unmet needs on MDS.A KOL describes the treatment pathways for lower- and higher-risk MDS patients and discusses current treatment and reimbursement challenges. Key clinical trials and drugs in active development are also discussed as well as unmet needs on MDS.

This interview was conducted on 06 September, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900.